Electromed (ELMD) Net Equity Issued and Repurchased (2010 - 2019)
Electromed's (ELMD) quarterly Net Equity Issued and Repurchased came in at $13040.0 in Q3 2019, down 61.15% year-over-year from $33568.0 in Q3 2018, and down 61.15% quarter-over-quarter from $33568.0 in Q3 2018.
Powered by 
Analysis
Electromed (ELMD) Net Equity Issued and Repurchased (2010 - 2019) Analysis & Trends
Electromed (ELMD) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $13040.0 the latest figure, recorded in Q3 2019.
- On a quarterly basis, Net Equity Issued and Repurchased fell 61.15% year-over-year to $13040.0 in Q3 2019; TTM through Sep 2019 was $46608.0, a 71.59% increase from a year earlier, with the FY2012 full-year figure at $5.9 million, down 6.56% from the prior year.
- Net Equity Issued and Repurchased was $13040.0 for Q3 2019 at Electromed, down from $33568.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $33568.0 in Q3 2018 and troughed at $13040.0 in Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Electromed | 222.94 Mn | 202.49 Mn | 15.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 13,040.00 |
| Sep 30, 2018 | 33,568.00 |
| Dec 31, 2010 | -6,405.00 |
| Sep 30, 2010 | 6.37 Mn |